002252 上海莱士
已收盘 03-06 15:00:00
资讯
新帖
简况
上海莱士：血液制品在临床急救、重症救治等场景中发挥重要临床支持作用
证券之星 · 03-04
上海莱士：血液制品在临床急救、重症救治等场景中发挥重要临床支持作用
上海莱士(002252)2月13日股东户数11.43万户，较上期减少0.76%
证券之星 · 03-02
上海莱士(002252)2月13日股东户数11.43万户，较上期减少0.76%
上海莱士（002252）披露2025年前三季度权益分派实施公告，2月2日股价下跌0.63%
证券之星 · 02-02
上海莱士（002252）披露2025年前三季度权益分派实施公告，2月2日股价下跌0.63%
上海莱士（002252）披露全资子公司获得《药品注册证书》，1月30日股价下跌0.94%
证券之星 · 01-30
上海莱士（002252）披露全资子公司获得《药品注册证书》，1月30日股价下跌0.94%
股市必读：上海莱士（002252）1月28日董秘有最新回复
证券之星 · 01-29
股市必读：上海莱士（002252）1月28日董秘有最新回复
上海莱士：公司核心产品为人源性血液制品
证券之星 · 01-28
上海莱士：公司核心产品为人源性血液制品
上海莱士：公司已建立常态化管控机制
证券之星 · 01-23
上海莱士：公司已建立常态化管控机制
上海莱士：持续优化高管薪酬与绩效考核体系
证券之星 · 01-22
上海莱士：持续优化高管薪酬与绩效考核体系
上海莱士：截至2026年1月20日股东户数为110,824户
证券之星 · 01-22
上海莱士：截至2026年1月20日股东户数为110,824户
上海莱士(002252)1月9日股东户数10.93万户，较上期减少0.09%
证券之星 · 01-19
上海莱士(002252)1月9日股东户数10.93万户，较上期减少0.09%
股市必读：上海莱士（002252）1月16日董秘有最新回复
证券之星 · 01-19
股市必读：上海莱士（002252）1月16日董秘有最新回复
上海莱士：公司运营一切正常
证券之星 · 01-16
上海莱士：公司运营一切正常
股市必读：上海莱士(002252)股东户数10.94万户，较上期减少0.72%
证券之星 · 01-09
股市必读：上海莱士(002252)股东户数10.94万户，较上期减少0.72%
上海莱士：截至2025年12月31日股东户数为109,405户
证券之星 · 01-08
上海莱士：截至2025年12月31日股东户数为109,405户
上海莱士：截至2025年12月19日股东户数为110,196户
证券之星 · 2025-12-26
上海莱士：截至2025年12月19日股东户数为110,196户
上海莱士（002252）公司公告选举产生第六届董事会职工代表董事，12月17日股价下跌0.47%
证券之星 · 2025-12-17
上海莱士（002252）公司公告选举产生第六届董事会职工代表董事，12月17日股价下跌0.47%
上海莱士(002252)12月10日股东户数10.98万户，较上期减少0.33%
证券之星 · 2025-12-15
上海莱士(002252)12月10日股东户数10.98万户，较上期减少0.33%
12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
证券之星 · 2025-12-15
12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股
上海莱士：截至2025年10月31日股东总户数为111,626户
证券之星 · 2025-12-05
上海莱士：截至2025年10月31日股东总户数为111,626户
上海莱士：截至2025年11月28日股东户数为110,144户
证券之星 · 2025-12-02
上海莱士：截至2025年11月28日股东户数为110,144户
加载更多
公司概况
公司名称：
上海莱士血液制品股份有限公司
所属行业：
医药制造业
上市日期：
2008-06-23
主营业务：
上海莱士血液制品股份有限公司的主营业务是血液制品的生产和销售。公司的主要产品是自产白蛋白、进口白蛋白、静丙、其他血液制品、检测设备及试剂。公司是“上海市外商投资先进技术企业”、“高新技术企业”。
发行价格：
12.81
{"stockData":{"symbol":"002252","market":"SZ","secType":"STK","nameCN":"上海莱士","latestPrice":6.24,"timestamp":1772780625000,"preClose":6.17,"halted":0,"volume":24251717,"delay":0,"changeRate":0.0113,"floatShares":6634000000,"shares":6638000000,"eps":0.2752,"marketStatus":"已收盘","change":0.07,"latestTime":"03-06 15:00:00","open":6.16,"high":6.25,"low":6.15,"amount":151000000,"amplitude":0.0162,"askPrice":6.25,"askSize":10195,"bidPrice":6.24,"bidSize":3357,"shortable":0,"etf":0,"ttmEps":0.2752,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773019800000},"marketStatusCode":5,"adr":0,"adjPreClose":6.17,"symbolType":"stock","openAndCloseTimeList":[[1772760600000,1772767800000],[1772773200000,1772780400000]],"highLimit":6.79,"lowLimit":5.55,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":6637984837,"isCdr":false,"pbRate":1.26,"roa":"--","peRate":22.674419,"roe":"4.55%","epsLYR":0.33,"committee":-0.141223,"marketValue":41421000000,"turnoverRate":0.0037,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-09。","floatMarketCap":41399000000},"requestUrl":"/m/hq/s/002252","defaultTab":"news","newsList":[{"id":"2616533703","title":"上海莱士：血液制品在临床急救、重症救治等场景中发挥重要临床支持作用","url":"https://stock-news.laohu8.com/highlight/detail?id=2616533703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616533703?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:15","pubTimestamp":1772615719,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)03月04日在投资者关系平台上答复投资者关心的问题。投资者提问：最近区域冲突不断，请问血制品对军方来说是否为强需求？上海莱士回复：您好！感谢您对我公司的关心和支持！血液制品在临床急救、重症救治等场景中，发挥着重要的临床支持作用，是保障患者生命安全的重要医疗资源之一。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400030072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002252","BK0046","BK0239","BK0188","BK0196"],"gpt_icon":0},{"id":"2616738768","title":"上海莱士(002252)2月13日股东户数11.43万户，较上期减少0.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616738768","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616738768?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:28","pubTimestamp":1772443736,"startTime":"0","endTime":"0","summary":"证券之星消息，近日上海莱士披露，截至2026年2月13日公司股东户数为11.43万户，较1月30日减少875.0户，减幅为0.76%。在生物制品行业个股中，上海莱士股东户数高于行业平均水平，截至2月13日，生物制品行业平均股东户数为3.46万户。从股价来看，2026年1月30日至2026年2月13日，上海莱士区间跌幅为0.64%，在此期间股东户数减少875.0户，减幅为0.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0046","BK0188","002252","BK0028"],"gpt_icon":0},{"id":"2608857421","title":"上海莱士（002252）披露2025年前三季度权益分派实施公告，2月2日股价下跌0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608857421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608857421?lang=zh_cn&edition=full","pubTime":"2026-02-02 18:02","pubTimestamp":1770026524,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，上海莱士报收于6.26元，较前一交易日下跌0.63%，最新总市值为415.54亿元。该股当日开盘6.3元，最高6.32元，最低6.25元，成交额达2.18亿元，换手率为0.52%。上海莱士血液制品股份有限公司于近日披露《2025年前三季度权益分派实施公告》。本次实际现金分红总额为100,504,214.14元，折算每10股现金红利为0.151407元。股权登记日为2026年2月9日，除权除息日为2026年2月10日。公司回购股份69,081,952股不参与本次分红。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200027384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0028","002252","BK0239","BK0188"],"gpt_icon":0},{"id":"2607041663","title":"上海莱士（002252）披露全资子公司获得《药品注册证书》，1月30日股价下跌0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607041663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607041663?lang=zh_cn&edition=full","pubTime":"2026-01-30 22:30","pubTimestamp":1769783440,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，上海莱士报收于6.3元，较前一交易日下跌0.94%，最新总市值为418.19亿元。该股当日开盘6.34元，最高6.37元，最低6.27元，成交额达2.58亿元，换手率为0.62%。上海莱士近日披露公告显示，其全资子公司同路生物制药有限公司近日收到国家药品监督管理局签发的《药品注册证书》，药品名称为人纤维蛋白原，剂型为注射剂，注册分类为治疗用生物制品，适应症为先天性纤维蛋白原减少或缺乏症。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000047434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0028","BK0188","002252","BK0196"],"gpt_icon":0},{"id":"2607974911","title":"股市必读：上海莱士（002252）1月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2607974911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607974911?lang=zh_cn&edition=full","pubTime":"2026-01-29 01:42","pubTimestamp":1769622137,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，上海莱士报收于6.35元，下跌0.63%，换手率0.85%，成交量56.33万手，成交额3.58亿元。董秘最新回复投资者： 1.请问贵公司产品可用于尼帕病毒检测吗？目前，公司无相关产品用于尼帕病毒检测；也暂无与上海药物研究所有合作。此外，公司“脱浆”战略着眼于创新突破，在夯实血液制品研发基础的同时，积极向生物制药其他高附加值领域拓展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900001028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","002252","BK0188","BK0239","BK0028","BK0196"],"gpt_icon":0},{"id":"2606799566","title":"上海莱士：公司核心产品为人源性血液制品","url":"https://stock-news.laohu8.com/highlight/detail?id=2606799566","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606799566?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:57","pubTimestamp":1769590635,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士01月28日在投资者关系平台上答复投资者关心的问题。公司目前无相关同类的产品，也未开展该类产品的研发。公司核心产品为人源性血液制品，如人血白蛋白、静注人免疫球蛋白、凝血因子类等产品。血液制品在临床急救及相关危急重症场景中发挥着关键的作用。此外，公司“脱浆”战略着眼于创新突破，在夯实血液制品研发基础的同时，积极向生物制药其他高附加值领域拓展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800028528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0046","BK0188","BK0239","BK0028","002252"],"gpt_icon":0},{"id":"2605647097","title":"上海莱士：公司已建立常态化管控机制","url":"https://stock-news.laohu8.com/highlight/detail?id=2605647097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605647097?lang=zh_cn&edition=full","pubTime":"2026-01-23 20:51","pubTimestamp":1769172687,"startTime":"0","endTime":"0","summary":"上市公司股价受市场、政策等多重因素影响。公司已建立常态化管控机制，一方面持续跟踪商誉相关标的经营情况，通过优化标的业务布局、强化协同整合、提升运营效率等方式，保障标的盈利能力稳定；另一方面将严格按照会计准则要求，每年年终聘请审计机构和评估机构进行商誉减值测试，及时、准确披露相关情况。每年年末，公司会聘请专业的评估和审计机构对长期股权投资进行减值测试。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300040049.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","002252","BK0028","BK0046","BK0196","BK0239"],"gpt_icon":0},{"id":"2605469825","title":"上海莱士：持续优化高管薪酬与绩效考核体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2605469825","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605469825?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:51","pubTimestamp":1769071879,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士01月22日在投资者关系平台上答复投资者关心的问题。制度也明确约定了高管薪酬确定原则、绩效考核体系、方案审批流程等核心条款。未来，公司将积极借鉴优秀公司的实践经验，结合自身经营发展需要，持续科学优化高管薪酬与绩效考核体系，更好地平衡激励效果与股东利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200026795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0028","BK0239","002252","BK0046","BK0188"],"gpt_icon":0},{"id":"2605660324","title":"上海莱士：截至2026年1月20日股东户数为110,824户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605660324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605660324?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:48","pubTimestamp":1769071700,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)01月22日在投资者关系平台上答复投资者关心的问题。投资者提问：问下1/20的股东人数上海莱士回复：您好！感谢您对我公司的关心和支持！截至2026年1月20日，公司股东总户数为110,824户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200026708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0046","002252","BK0028","BK0239"],"gpt_icon":0},{"id":"2604849741","title":"上海莱士(002252)1月9日股东户数10.93万户，较上期减少0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604849741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604849741?lang=zh_cn&edition=full","pubTime":"2026-01-19 17:27","pubTimestamp":1768814877,"startTime":"0","endTime":"0","summary":"证券之星消息，近日上海莱士披露，截至2026年1月9日公司股东户数为10.93万户，较12月31日减少93.0户，减幅为0.09%。在生物制品行业个股中，上海莱士股东户数高于行业平均水平，截至1月9日，生物制品行业平均股东户数为3.44万户。从股价来看，2025年12月31日至2026年1月9日，上海莱士区间涨幅为2.05%，在此期间股东户数减少93.0户，减幅为0.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900023292.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0196","002252","BK0028","BK0188","BK0046"],"gpt_icon":0},{"id":"2604971327","title":"股市必读：上海莱士（002252）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604971327","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604971327?lang=zh_cn&edition=full","pubTime":"2026-01-19 01:41","pubTimestamp":1768758069,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，上海莱士报收于6.3元，下跌1.41%，换手率0.73%，成交量48.55万手，成交额3.08亿元。董秘最新回复投资者： 目前公司营运正常吗？感谢您对我公司的关心和支持！目前，公司运营一切正常，各项业务均有序推进。交易信息汇总资金流向1月16日主力资金净流出3206.5万元；游资资金净流入4392.2万元；散户资金净流出1185.7万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900000594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002252","BK0028","BK0196","BK0188","BK0046"],"gpt_icon":0},{"id":"2603969388","title":"上海莱士：公司运营一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2603969388","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603969388?lang=zh_cn&edition=full","pubTime":"2026-01-16 17:00","pubTimestamp":1768554037,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)01月16日在投资者关系平台上答复投资者关心的问题。投资者提问：目前公司营运正常吗？上海莱士回复：您好！感谢您对我公司的关心和支持！目前，公司运营一切正常，各项业务均有序推进。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600026959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0196","BK0028","BK0188","002252"],"gpt_icon":0},{"id":"2602681394","title":"股市必读：上海莱士(002252)股东户数10.94万户，较上期减少0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602681394","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602681394?lang=zh_cn&edition=full","pubTime":"2026-01-09 01:55","pubTimestamp":1767894912,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，上海莱士报收于6.44元，上涨0.62%，换手率0.39%，成交量26.05万手，成交额1.68亿元。来自股本股东变化：截至2025年12月31日，公司股东户数环比下降0.72%，户均持股上升至6.07万股，筹码集中度有所提升。股本股东变化股东户数变动近日上海莱士披露，截至2025年12月31日公司股东户数为10.94万户，较12月19日减少791.0户，减幅为0.72%。户均持股数量由上期的6.02万股增加至6.07万股，户均持股市值为38.47万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900001187.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002252","BK0028","BK0196","BK0188","BK0046"],"gpt_icon":0},{"id":"2601338512","title":"上海莱士：截至2025年12月31日股东户数为109,405户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601338512","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601338512?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:51","pubTimestamp":1767833466,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)01月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月31日的股东人数是多少？谢谢上海莱士回复：您好！感谢您对我公司的关心和支持！ 截至2025年12月31日，公司股东总户数为109,405户。 谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800006208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","BK0046","BK0196","002252"],"gpt_icon":0},{"id":"2594263787","title":"上海莱士：截至2025年12月19日股东户数为110,196户","url":"https://stock-news.laohu8.com/highlight/detail?id=2594263787","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594263787?lang=zh_cn&edition=full","pubTime":"2025-12-26 11:33","pubTimestamp":1766720037,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)12月26日在投资者关系平台上答复投资者关心的问题。投资者提问：问下12/19的股东人数上海莱士回复：您好！感谢您对我公司的关心和支持！ 截至2025年12月19日，公司股东总户数为110,196户。 谢谢以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600012472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0196","BK0028","BK0188","002252"],"gpt_icon":0},{"id":"2592012913","title":"上海莱士（002252）公司公告选举产生第六届董事会职工代表董事，12月17日股价下跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592012913","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592012913?lang=zh_cn&edition=full","pubTime":"2025-12-17 22:12","pubTimestamp":1765980745,"startTime":"0","endTime":"0","summary":"截至2025年12月17日收盘，上海莱士报收于6.36元，较前一交易日下跌0.47%，最新总市值为422.18亿元。该股当日开盘6.35元，最高6.38元，最低6.28元，成交额达1.68亿元，换手率为0.4%。近日，上海莱士发布关于选举产生第六届董事会职工代表董事的公告。公告称，公司于2025年12月16日召开职工代表大会，选举占德国先生为第六届董事会职工代表董事，任期至第六届董事会任期届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121700039352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0188","BK0046","BK0196","002252"],"gpt_icon":0},{"id":"2591612143","title":"上海莱士(002252)12月10日股东户数10.98万户，较上期减少0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591612143","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591612143?lang=zh_cn&edition=full","pubTime":"2025-12-15 17:44","pubTimestamp":1765791897,"startTime":"0","endTime":"0","summary":"证券之星消息，近日上海莱士披露，截至2025年12月10日公司股东户数为10.98万户，较11月28日减少360.0户，减幅为0.33%。在生物制品行业个股中，上海莱士股东户数高于行业平均水平，截至12月10日，生物制品行业平均股东户数为3.45万户。从股价来看，2025年11月28日至2025年12月10日，上海莱士区间跌幅为2.26%，在此期间股东户数减少360.0户，减幅为0.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500022308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002252","BK0046","BK0239","BK0188","BK0196"],"gpt_icon":0},{"id":"2591153066","title":"12月15日上海莱士创60日新低，招商国证生物医药指数(LOF)C基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2591153066","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591153066?lang=zh_cn&edition=full","pubTime":"2025-12-15 15:37","pubTimestamp":1765784229,"startTime":"0","endTime":"0","summary":"证券之星消息，12月15日上海莱士创60日新低，收盘报6.34元，当日跌1.55%，换手率0.52%，成交量34.48万手，成交额2.2亿元。重仓上海莱士的前十大公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共12家，其中持有数量最多的公募基金为招商基金的招商国证生物医药指数C。招商国证生物医药指数C目前规模为15.39亿元，最新净值0.4037，较上一交易日上涨0.45%，近一年下跌1.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500013020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","161726","BK0196","BK0188","BK0028","399441","002252"],"gpt_icon":0},{"id":"2589867133","title":"上海莱士：截至2025年10月31日股东总户数为111,626户","url":"https://stock-news.laohu8.com/highlight/detail?id=2589867133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589867133?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:27","pubTimestamp":1764923242,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止10月31日，公司总的股东户数是多少？谢谢。上海莱士回复：您好！感谢您对我公司的关心和支持！截至2025年10月31日，公司股东总户数为111,626户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500022004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0196","BK0028","BK0188","002252"],"gpt_icon":0},{"id":"2588033948","title":"上海莱士：截至2025年11月28日股东户数为110,144户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588033948","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588033948?lang=zh_cn&edition=full","pubTime":"2025-12-02 16:27","pubTimestamp":1764664029,"startTime":"0","endTime":"0","summary":"证券之星消息，上海莱士(002252)12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！请问截止11月30号，公司的股东人数是多少？谢谢上海莱士回复：您好！感谢您对我公司的关心和支持！截至2025年11月28日，公司股东总户数为110,144户。谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200021162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","BK0196","002252","BK0239","BK0188"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772935046920,"stockEarnings":[{"period":"1week","weight":-0.0079},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0565},{"period":"6month","weight":-0.0869},{"period":"1year","weight":-0.0838},{"period":"ytd","weight":-0.0134}],"compareEarnings":[{"period":"1week","weight":-0.0093},{"period":"1month","weight":0.0054},{"period":"3month","weight":0.0567},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.2198},{"period":"ytd","weight":0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海莱士血液制品股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"114288人(较上一季度减少0.33%)","perCapita":"58050股","listingDate":"2008-06-23","address":"上海市奉贤区望园路2009号","registeredCapital":"663798万元","survey":" 上海莱士血液制品股份有限公司的主营业务是血液制品的生产和销售。公司的主要产品是自产白蛋白、进口白蛋白、静丙、其他血液制品、检测设备及试剂。公司是“上海市外商投资先进技术企业”、“高新技术企业”。","listedPrice":12.81},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海莱士(002252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海莱士(002252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海莱士,002252,上海莱士股票,上海莱士股票老虎,上海莱士股票老虎国际,上海莱士行情,上海莱士股票行情,上海莱士股价,上海莱士股市,上海莱士股票价格,上海莱士股票交易,上海莱士股票购买,上海莱士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海莱士(002252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海莱士(002252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}